In the past, the majority of companies were rather naive regarding their options for sourcing comparator medications. Some companies, even large ones, were relying on local pharmacies, and almost all had no consistent sourcing strategy. A lot has changed since then. Michael Cohen from Myoderm provides an overview on The EU Clinical Trial Directive. The development of many “speciality suppliers” for comparators, and the increasing number, size, and complexities of clinical trials have encouraged sponsor companies to adopt a more sophisticated approach to the procurement of these essential products.
 
You can download this PDF issue for only £2
[purchase_link id=”967″ text=”Purchase” style=”button” color=”gray”]